Concourse Financial Group Securities’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-105
| Closed | -$19K | – | 10386 |
|
|
2021
Q2 | $19K | Sell |
105
-29
| -22% | -$5.25K | ﹤0.01% | 1669 |
|
|
2021
Q1 | $20K | Sell |
134
-189
| -59% | -$28.2K | ﹤0.01% | 1571 |
|
|
2020
Q4 | $50K | Buy |
323
+13
| +4% | +$2.01K | ﹤0.01% | 1153 |
|
|
2020
Q3 | $35K | Buy |
310
+108
| +53% | +$12.2K | ﹤0.01% | 1183 |
|
|
2020
Q2 | $23K | Sell |
202
-1,707
| -89% | -$194K | ﹤0.01% | 1254 |
|
|
2020
Q1 | $171K | Buy |
+1,909
| New | +$171K | 0.02% | 504 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7104 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6922 |
|
|
2019
Q2 | – | Sell |
-544
| Closed | -$73K | – | 6856 |
|
|
2019
Q1 | $73K | Buy |
544
+336
| +162% | +$45.1K | 0.01% | 757 |
|
|
2018
Q4 | $20K | Buy |
208
+13
| +7% | +$1.25K | ﹤0.01% | 1161 |
|
|
2018
Q3 | $27K | Buy |
+195
| New | +$27K | 0.01% | 773 |
|